Stocks and Investing Stocks and Investing
Fri, September 22, 2017
[ 12:00 AM ] - WOPRAI
David Steinberg Initiated (SVRA) at Strong Buy and Held Target at $20 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Fintan Ryan Initiated (SXT) at Strong Buy and Held Target at $88 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Kenneth Wong Initiated (TYL) at Strong Buy and Held Target at $200 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Ana Gupte Maintained (UHS) at Buy with Increased Target to $132 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Paul Newsome Upgraded (UFCS) to Strong Buy on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Tom Forte Initiated (YELP) at Strong Buy and Held Target at $51 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Novid Rassouli Downgraded (X) to Sell on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Ying Huang Maintained (BOLD) at Strong Buy with Increased Target to $33 on, Sep 22nd, 2017
Thu, September 21, 2017
[ 12:00 AM ] - WOPRAI
Nicole Deblase Downgraded (TEX) to Hold on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Rob Oliver Maintained (WK) at Hold with Increased Target to $20 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Ambrish Srivastava Maintained (TXN) at Buy with Increased Target to $105 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Benjamin Swinburne Maintained (BATRK) at Sell with Increased Target to $25 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Benjamin Swinburne Maintained (BATRA) at Sell with Increased Target to $25 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Paul Matteis Maintained (ALNY) at Hold with Increased Target to $112 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Alethia Young Maintained (ALNY) at Buy with Increased Target to $123 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Alan Carr Maintained (ALNY) at Strong Buy with Increased Target to $125 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
David Lebovitz Maintained (ALNY) at Hold with Increased Target to $101 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Geoff Meacham Maintained (ALNY) at Buy with Increased Target to $127 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Jacob Kilstein Initiated (BHF) at Hold on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Christopher Raymond Downgraded (BIIB) to Hold on, Sep 21st, 2017
Wed, September 20, 2017
[ 12:00 AM ] - WOPRAI
James Faucette Upgraded (ANET) to Buy on, Sep 20th, 2017
[ 12:00 AM ] - WOPRAI
Brent Thill Maintained (ADBE) at Strong Buy with Increased Target to $180 on, Sep 20th, 2017
[ 12:00 AM ] - WOPRAI
Richard Davis Maintained (ADBE) at Strong Buy with Increased Target to $170 on, Sep 20th, 2017
[ 12:00 AM ] - WOPRAI
Robyn Karnauskas Initiated (BIIB) at Strong Buy and Held Target at $360 on, Sep 20th, 2017
[ 12:00 AM ] - WOPRAI
Savanthi Syth Upgraded (AAL) to Buy on, Sep 20th, 2017
[ 12:00 AM ] - WOPRAI
Michael Weinstein Initiated (VST) at Buy and Held Target at $20 on, Sep 20th, 2017
[ 12:00 AM ] - WOPRAI
Scott Krasik Initiated (TTWO) at Strong Buy and Held Target at $120 on, Sep 20th, 2017
[ 12:00 AM ] - WOPRAI
Savanthi Syth Downgraded (UAL) to Hold on, Sep 20th, 2017
[ 12:00 AM ] - WOPRAI
Sheila Kahyaoglu Downgraded (TDG) to Hold on, Sep 20th, 2017
[ 12:00 AM ] - WOPRAI
Arlinda Lee Maintained (BPMC) at Strong Buy with Increased Target to $66 on, Sep 20th, 2017

Arlinda Lee Maintained (BPMC) at Strong Buy with Increased Target to $66 on, Sep 20th, 2017


Published on 2024-10-25 22:55:16 - WOPRAI, Arlinda Lee
  Print publication without navigation


Arlinda Lee of Canaccord Genuity, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $56 to $66 on, Sep 20th, 2017.

Arlinda, nor any peers, have made any analyst calls on BPMC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources